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Abstract
Purpose To study the thyroid image reporting and data sys-
tem (TI-RADS) classification and the contrast-enhanced ultra-
sound (CEUS) enhancement pattern of thyroid nodules, and to
determine whether combined use of both methods is helpful in
the diagnosis of thyroid nodules.
Methods A total of 319 thyroid nodules in 246 patients were
assessed with TI-RADS, CEUS and a combination of both
methods. The diagnostic performance of TI-RADS, CEUS
and a combination of both methods was compared.
Results The accuracy in the diagnosis of thyroid nodules
was 90.3 % for TI-RADS, 90.0 % for CEUS and 96.0 %
for a combination of both methods respectively. A statisti-
cally significant difference was not observed in the diagnos-
tic accuracy of CEUS and TI-RADS (P > 0.05). However, a
significant difference was observed between a combination
of both methods and either alone (P < 0.01). A combination
of both methods showed high sensitivity, specificity and
accuracy for TI-RADS classifications of 4a and 4b thyroid
nodules compared with TI-RADS alone (P < 0.01) and a
statistically significant difference was not observed for thy-
roid nodules classified as 2, 3, and 5 (P > 0.05).
Conclusions The improved TI-RADS, when combined with
CEUS, could significantly improve the diagnostic accuracy
for thyroid nodules, especially for TI-RADS class-4 thyroid
nodules.
Key Points
• TI-RADS can be used as the primary diagnostic standard for
thyroid nodules
• CEUS can be used as an important complement to TI-RADS
• The improved TI-RADS can significantly improve the qual-
itative diagnostic accuracy
Keywords Thyroid nodules . TI-RADS . Contrast-enhanced
ultrasound . Combination . Improved TI-RADS
Abbreviations and acronyms
TI-RADS thyroid imaging reporting and data system
BI-RADS breast imaging reporting and data system
CEUS contrast-enhanced ultrasound
CPS contrast pulsed sequences
FNAB fine-needle aspiration biopsy
Introduction
The wide application of ultrasound (US) and other technolo-
gies in recent years has led to an increasing number of thyroid
nodule diagnoses [1]. The pathological nature of thyroid nod-
ules directly affects the therapeutic methodology and patient
prognosis; therefore, the correct diagnosis of thyroid nodules
at an early stage has important clinical significance. However,
conventional sonographic diagnoses for thyroid nodules pre-
sents limitations related to overlapping boundaries, morphol-
ogies, internal blood streams, and echoes between malignant
and benign nodules. In addition, subjective factors related to
the diagnostician can also affect the accuracy of the diagnosis.
Therefore, research by Park et al. [2], Horvath et al. [3] and
Kwak et al. [4] indicates that the thyroid imaging reporting
and data system (TI-RADS), which is based on the breast
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imaging reporting and data system (BI-RADS), can be used to
improve the diagnostic accuracy of thyroid nodules by US,
which will provide improvements that can be used in clinical
practice.
Contrast-enhanced ultrasound (CEUS) is a focus of current
medical US research. CEUS has developed rapidly and is now
widely used in many areas of medical US, particularly in
diagnoses of liver tumour, and it has greatly improved the
specificity and sensitivity of US diagnoses and achieved great
clinical value. In recent years, an increasing number of CEUS
applications have been developed for thyroid diagnoses in
clinical practice, and a number of investigations have been
performed to evaluate the different contrast modes in the di-
agnosis of thyroid nodules. Studies have reported that CEUS
can help accurately diagnose both benign and malignant thy-
roid nodules [5–10].
Currently, studies have reported that both TI-RADS and
CEUS can effectively diagnose thyroid nodules; thus, a new
scale standard for TI-RADS classification that includes CEUS
should be proposed. This paper presents the results of studies
performed on 319 thyroid nodules in 246 thyroid patients
using TI-RADS, CEUS and combined method with the goal
of investigating the value of diagnosing thyroid nodules with
the combined CEUS and TI-RADS classification and




In this study, 246 patients who had received conventional US
examinations and CEUS examinations as well as postopera-
tive pathological diagnoses or fine-needle aspiration biopsies
(FNABs) between December 2012 and December 2014 in our
hospital were recruited. In total, 319 nodule lesions were iden-
tified. The patients included 161 women and 85 men; their
ages ranged from 19-74 years, and the average was (46.1
± 15.2) years. The diameter range of the lesions was 2.5-
46 mm, and the average was (11.9 ± 3.3) mm. FNAB was
performed on 230 nodules, and resection was performed on
89 nodules. The details of the pathological types of thyroid
nodules are as follows: 319 nodules included 244 benign nod-
ules and 75 malignant nodules; the benign nodules included
210 nodular goitres, 23 adenomas, 6 adenomatous nodular
goitres and 5 inflammatory nodules, and there were 8 thyroid
nodules coexisting with Hashimoto s thyroiditis in 210 nodu-
lar goitres; and the malignant nodules included 58 papillary
carcinomas, 8 nodular goitres with complications of local pap-
illary carcinoma, 4 follicular carcinomas, 4 nodular goitres
with complications of local follicular cancer and 1 medullary
carcinoma. All of the lesions were accompanied by postoper-
ative pathological results or FNAB results. The present study
was approved by the hospital ethics committee, and all of the
patients provided informed consent.
Instruments and examination methods
The instrument used in the diagnoses performed here is a
Siemens Acuson S2000 colour Doppler US system
(Siemens; Mountain View, CA, USA), with contrast pulsed
sequencing (CPS) and equipped with an 14 L5 transducer for
conventional US and an 9 L4 transducer for CEUS. Every
section of the thyroid was carefully scanned, the ultrasonic
characteristics of the thyroid structure were observed and re-
corded, and the images were saved. TI-RADS was used to











Score 1 0 0 0 0
Score 2 68 68 0 0
Score 3 100 97 3 3.0
Score 4a 65 58 7 10.8
Score 4b 58 19 39 67.2
Score 5 28 2 26 92.9











Score 1 0 0 0 0
Score 2 23 23 0 0
Score 3 45 45 0 0
Score 4a 100 97 3 3.0
Score 4b 65 58 7 10.8
Score 4c 71 19 52 73.2
Score 5 15 2 13 86.7




Sensitivity Specificity Accuracy PPV NPV
Kwak TI-RADS 96.0 % 67.6 % 73.8 % 47.7 % 98.2 %
TI-RADS in the
present study
86.7 % 91.4 % 90.3 % 75.6 % 95.7 %
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evaluate and classify every thyroid nodule. The CPS tech-
nique and SonoVue contrast agent (Bracco, Milan, Italy) were
used. A 20-G needle was inserted into the patients peripheral
veins to establish intravenous access. The contrast agent was
mixed with 5 ml saline and shaken to homogeneity, and 2.4 ml
of the suspension was then quickly pushed into the peripheral
vein with the probe and body position unchanged, and the
patient was told not to swallow. The dynamic perfusion pro-
cess of the lesion was continuouslymonitored in real time, and
the images were saved on the hard drive of the ultrasound
diagnosis instrument.
All examinations were performed by an experienced radi-
ologist with more than a decade of experience each in US
diagnosis and more than 1 years’ experience of performing
CEUS of thyroid nodules in order to exclude the bias from
different operators. The US imaging data were respectively
analysed by two other experienced radiologists with more
than a decade of experience in US diagnosis and with more
than 1 years’ experience of performing CEUS. They per-
formed blind independent analyses of the TI-RADS and
CEUS images to retrospectively analyse the nature of the thy-
roid nodules. Then the combined methodology was compre-
hensively analysed by the third radiologist.
The 4a, 4b thyroid nodules which were categorised by TI-
RADS and a combination of TI-RADS and CEUS were stud-
ied retrospectively. The correlation between US or CEUS fea-
tures and pathological findings was analysed statistically.
Logistic regression was used to improve the analytical results.
The inter-observer variability between experienced and inex-
perienced examiners using TI-RADS and CEUS was evaluat-
ed retrospectively. The US imaging data were independently
analysed by an experienced and inexperienced examiner using
TI-RADS and CEUS, respectively.
Diagnostic criteria
TI-RADS diagnostic criteria
We have proposed a new classification standard based on the
TI-RADS classification criteria proposed by Park et al. [2],
Horvath et al. [3] and Kwak et al. [4], and the five ultrasound
signs (solid component, marked hypoechogenicity, irregular
margins, microcalcifications, taller than wide shape) proposed
by Kwak et al. [4]. The new standard was compared with the
TI-RADS classification standard proposed by Kwak et al. [4].
Kwak et al. [4] TI-RADS classification criteria:
TI-RADS score 1: normal thyroid
TI-RADS score 2: no malignant sign, benign lesions
TI-RADS score 3: no malignant sign, high probability of
benignity
TI-RADS score 4a: one malignant sign; possible benignity
TI-RADS score 4b: two malignant signs; possible
malignancy
TI-RADS score 4c: three or four malignant signs; high pos-
sibility of malignancy
TI-RADS score 5: five malignant signs, highly indicative of
malignancy
Table 4 CEUS enhancement







Low enhancement 73 58 15
Equal enhancement 65 13 52
High enhancement 74 2 72
Circular enhancement 107 2 105
Total 319 75 244











Score 1 0 0 0 0
Score 2 78 78 0 0
Score 3 102 101 1 1.0
Score 4a 56 55 1 1.6
Score 4b 52 8 44 75.0
Score 5 31 2 29 90.5
Table 6 Diagnostic performance of TI-RADS and CEUS
Examination
method
Sensitivity Specificity Accuracy PPV NPV
TI-RADS 86.7 % 91.4 % 90.3 % 75.6 % 95.7 %
CEUS 77.3 % 93.9 % 90.0 % 79.5 % 93.5 %
TI-RADS+CEUS 97.3 % 95.5 % 96.0 % 88.0 % 99.1 %
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TI-RADS classification criteria in the present study:
TI-RADS score 1: normal thyroid
TI-RADS score 2: no malignant sign, benign lesions
TI-RADS score 3: one malignant sign, high probability of
benignity
TI-RADS score 4a: two malignant signs, possible benignity
TI-RADS score 4b: three malignant signs, high probability
of malignancy
TI-RADS score 5: four to five malignant signs, highly sug-
gestive of malignancy
Benign andmalignant diagnostic criteria by TI-RADS clas-
sification: scores 1-4a are diagnosed as benign and scores 4b-5
are diagnosed as malignant.
CEUS diagnostic criteria
In the present study, the CEUS diagnostic criteria are divided
into circular enhancement, high enhancement, equal enhance-
ment and low enhancement based on the different US contrast
modes. If the contrast indicates high enhancement, circular
Fig. 1 A 35-year-old man was found to have an 8 × 6-mm solid
hypoechoic nodule in the left lobe of his thyroid. a A conventional two-
dimensional image. This nodule had three malignant indicators (solid,
markedly hypoechoic, and microcalcifications), and it was classified to
a 4b TI-RADS score. b The ultrasound contrast status and the enhance-
ment mode indicated high enhancement. The improved TI-RADS com-
bined with CEUS returned a score of 4a, which indicates a benign nodule.
c The pathological image of the lesion, which was of a nodular goitre
Fig. 2 A 42-year-old woman was found to have a 32 × 15-mm solid
nodule in the left lobe of her thyroid. a A conventional two-
dimensional image. This nodule had two malignant indicators (solid
and irregular margin), and it was classified to a 4a TI-RADS score. b
An ultrasound contrast image, and the enhancement mode indicates low
enhancement. The improved TI-RADS combined with CEUS returned a
score of 4b, and the diagnosis indicated a malignant nodule. c The
caepathological image of the lesion, which is a thyroid papillary
carcinoma
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enhancement or equal enhancement, then the nodule is diag-
nosed as benign. If the contrast indicates low enhancement,
then the nodule is diagnosed as malignant.
Improved TI-RADS diagnostic criteria in combination
with CEUS
If the CEUS indicates high enhancement or circular enhance-
ment, then one score is subtracted from the TI-RADS classi-
fication and score 2 is kept the same. If the CEUS indicates
low enhancement, then one score is added to the TI-RADS
classification, and score 5 remains the same. If the CEUS
indicates equal enhancement, then the TI-RADS classification
remains the same.
Statistical analysis
SPSS 19.0 software was used for the statistical analysis.
Quantitative data are expressed as the means ± standard devi-
ation. The χ2 test was used to compare the distribution of US
indicators for benign and malignant thyroid nodule. The sen-
sitivity, specificity, accuracy, positive prediction value (PPV)
Fig. 3 A 38-year-old woman was found to have a 12 × 12.5-mm solid
hypoechoic nodule in the left lobe of her thyroid. a A conventional two-
dimensional image. This nodule had three malignant indicators (solid,
aspect ratio greater than 1 and markedly hypoechoic) and was classified
to a 4b TI-RADS score. bAn ultrasound contrast image; the enhancement
mode was low enhancement. The improved TI-RADS combined with
CEUS returned a score of 5, and the diagnosis indicates a malignant
nodule. c The pathological image of the lesion, which is a thyroid papil-
lary carcinoma
Fig. 4 A 48-year-old woman was found to have a 14 × 12-mm solid
hypoechoic nodule in the right lobe of her thyroid. a A conventional
two-dimensional image. This nodule had fourmalignant indicators (solid,
irregular margin, markedly hypoechoic and microcalcifications); it was
classified to a TI-RADS score of 5. b An ultrasound contrast image; the
enhancementmodewas low enhancement. The improved TI-RADS com-
bined with CEUS returned a score of 5, and the diagnosis indicates a
malignant nodule. c The pathological image of the lesion, which is a
thyroid papillary carcinoma
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and negative prediction value (NPV) of the benign and malig-
nant thyroid nodule diagnoses by TI-RADS, CEUS and com-
bined method were calculated, and the χ2 test was used to
compare the three methods, with a value of P < 0.05
representing significant differences. The diagnostic accuracy
of score 2-5 thyroid nodules by a combination of both
methods and by TI-RADS alone was compared, with
P < 0.05 representing significant differences. In addition, lo-
gistic regression was used to evaluate the diagnostic perfor-
mance of the 4a, 4b thyroid nodules, which were categorised
by TI-RADS and a combination of TI-RADS and CEUS.
Inter-observer variability between experienced and inexperi-
enced examiners using TI-RADS and CEUS were obtained




The malignancy rates of TI-RADS score 2, score 3, score 4a
score 4b, score 5 were 0,3.0,10.8,67.2, and 92.9 %, respec-
tively (Table 1).
TI-RADS diagnostic classification by Kwak et al.
A comparative study was performed between the classifica-
tion criteria proposed by Kwak et al. [4] and the classification
criteria presented here, and the results show that there is a
significant difference between the two classification methods
(χ2 = 27.9, P < 0.01) (Tables 2 and 3).
CEUS results
Among the 75 malignant nodules in the present study,
58 (77.3 %) indicated low-enhancement mode, 13
(17.3 %) indicated equal enhancement mode, 2
(2.7 %) indicated high-enhancement mode and 2
(2.7 %) indicated circular enhancement. Among the
244 benign nodules, 15 (6.1 %) indicated low-
enhanced mode, and 229 (93.9 %) indicated equal en-
hancement, circular enhancement or high-enhancement
mode (Table 4).
Table 7 A combination of both methods of diagnosis of thyroid
nodules classified as 2-5
Classification Method Effective Ineffective P
Score 2 TI-RADS 68 0 >0.05
CEUS+TI-RADS 78 0
Score 3 TI-RADS 97 3 >0.05
CEUS+TI-RADS 101 1
Score 4a TI-RADS 58 7 0.01
CEUS+TI-RADS 55 1
Score 4b TI-RADS 39 19 0.01
CEUS+TI-RADS 44 8
Score 5 TI-RADS 26 2 >0.05
CEUS+TI-RADS 29 2
Table 8 Only TRIRADS criteria







Solid 1.519 0.659 0.021 4.566
Mixed 1
Echogenicity
Marked hypoechogenicity 1.429 0.622 0.021 4.176
Hyper/iso/hypoechogenicity 1
Margins
Irregular 1.713 0.653 0.009 5.547
Well circumscribed 1
Calcifications





Taller than wide 2.542 0.733 0.001 12.710
Wider than tall 1
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Accuracy of thyroid nodule diagnoses by CEUS combined
with TI-RADS
When CEUS and TI-RADS were used together for diag-
nosis, the malignancy rate of nodules classified as 4a and
below was decreased compared with that of TI-RADS
alone, whereas the malignancy rate of nodules classified
as 4b and above was increased compared with that of TI-
RADS alone (Table 5). The results from FNAB and path-
ological tests were used to verify the accuracy of the test-
ed methods, and the sensitivity, specificity, accuracy, PPV
and NPV of malignant thyroid nodule diagnoses by TI-
RADS, CEUS and the combined method were compared.
Significant differences were not observed between the di-
agnoses by CEUS alone and TI-RADS alone (χ2 = 0.01,
P > 0.05), whereas significant differences were observed
between the diagnoses of the combined method and that
of TI-RADS alone and CEUS alone (χ2 = 9.0, P < 0.01;
χ2 = 9.8, P < 0.01) (Table 6, Figs. 1, 2, 3 and 4).
A combination of both methods diagnoses of thyroid
nodules classified as 2-5
The results show that a significant difference occurred be-
tween the thyroid nodule diagnoses classified as 4a
(P < 0.01) and 4b (P < 0.01) by a combination of both
methods and TI-RADs alone, whereas a significant difference
was not observed for diagnoses classified as 2, 3 and 5
(P > 0.05) (Table 7).
Logistic regression analysis
At logistic regression analysis of 4a, 4b thyroid nodules, the
following features showed a association with malignancy: sol-
id component, marked hypoechogenicity, irregular margins,
microcalcifications, taller than wide shape and low enhance-
ment (Tables 8 and 9).
Inter-observer variability between experienced
and inexperienced examiners
The inter-examiner measurement agreement for TI-RADS
and CEUS had a high positive correlation even between ex-
perienced and inexperienced examiners (k = 0.885, k = 0.990,
respectively, Tables 10 and 11).
Table 9 TI-RADS with CEUS




P value Odds ratio
Composition
Solid 1.961 0.856 0.022 7.106
Mixed 1
Echogenicity
Marked hypoechogenicity 2.166 0.852 0.011 8.722
Hyper/iso/hypoechogenicity 1
Margins
Irregular 2.325 0.835 0.005 10.229
Well circumscribed 1
Calcifications
Microcalcifications 2.487 0.882 0.005 12.029
Macrocalcifications/no calcifications 1
Shape
Taller than wide 2.652 0.863 0.002 14.182
Wider than tall 1
CEUS
Hypoenhanced 2.898 0.845 0.001 18.134
Iso/hyper/annular enhanced constant term -7.743 1.924 0.000 0.000
Table 10 Inter-observer variability of TI-RADS
Observers 2 3 4a 4b 5 k
Experienced examiner 84 97 61 49 28 0.886
Inexperienced examiner 75 107 47 57 33
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Discussion
Early diagnosis, correct identification and diagnosis of the
benignity and malignancy of thyroid nodules has important
significance for clinical treatment method selections and prog-
nosis predictions. TI-RADS classification identifies the benig-
nity and malignancy of nodules through a comprehensive
analysis of nodulemorphological characteristics, and this clas-
sification provides a standard for the diagnosis of thyroid nod-
ules; however, improvements can be made in its application
for the identification of benignity and malignancy among thy-
roid nodules [2–4, 11]. CEUS is a recently developed ultra-
sound imaging technology, and studies have shown that mon-
itoring microcirculation perfusions after the injection of
microbubble contrast agents can be used to identify the benig-
nity and malignancy of thyroid nodules [5–10]. However, to
our knowledge, studies presenting TI-RADS classification
criteria that also consider CEUS diagnoses have not been re-
ported. Thus, the primary goal of the present study was to
develop a new and effective TI-RADS classification standard
by investigating the value of diagnosing thyroid nodules using
CEUS combined with TI-RADS and determining whether
improvements were made to the diagnostic accuracy.
Currently, a number of scholars have begun applying TI-
RADS classifications to thyroid nodules [2–4]; however, a
generalised standard has not been developed. In the present
study, we have referenced BI-RADS classifications and the
classifications by Park et al. [2], Horvath et al. [3] and Kwak
et al. [4] to classify thyroid nodules as score 1-5, with score 4
divided into the subscores 4a and 4b. Clinical practice has
confirmed that this classification is simple and practical. To
develop an objective classification, the American scholar
Horvath et al. [3] first proposed a classification using ten US
sonographic characteristics, whereas Park et al. [2] proposed
using 12 US sonographic characteristics. Recently, Korean
scholars Kwak et al. [4] proposed using five ultrasound sono-
graphic characteristics for the classification, and these charac-
teristics are simple and generalised, and highly practical in
clinical practice. Therefore, in the present study, we used these
five US signs for the classification of each thyroid nodule,
although certain flaws were noted [4]. In the classification,
malignant indicators are not available for scores 2 and 3; there-
fore, the difference between these two scores is vague. In the
present study, we separated score 2 from score 3 and classified
nodules with one malignant sign as score 3. This classification
facilitates the standardisation of scores 2 and 3, and reduces
the subjectivity of their classification. In addition, the standard
presented here classifies nodules with one malignant sign as
score 4a and nodules with two malignant signs as score 4b;
thus, there may be higher false-positive rates.
To verify the accuracy and effectiveness of the classifica-
tion standard in the present study, we performed a comparative
analysis with the classification method by Kwak et al. [4]. The
results showed that our classification method has a higher
accuracy than the classification method by Kwak et al.
(90.3 % vs 73.8 %). Moreover, because the criteria presented
here classify nodules with two malignant signs as score 4a and
nodules with three malignant signs as score 4b, the false-
positive rate is significantly reduced, which may prevent un-
necessary surgical treatment. In the present study, we
misdiagnosed 31 nodules based on TI-RADS standards,
which accounted for 9.7 % of the diagnoses. The
misdiagnosed nodules were mainly in scores 4a and 4b, indi-
cating that these two scores have a degree of overlap.
As an important technique in US medicine, CEUS has
played an important role in the diagnosis of thyroid lesions over
the last decade [5–10, 12]. Studies from numerous researchers
suggest that most of the contrasts indicating low enhancement
and heterogeneous enhancement are malignant thyroid nodules
[5, 9], whereas most contrast modes indicating high enhance-
ment and circular enhancement are benign nodules [7]. CEUS
has been proposed to evaluate the thyroid nodules and the sen-
sitivity, specificity and accuracy for the diagnosis of malignant
thyroid nodules were reported to be 76.9–88.2 %, 84.8–95.1 %
and 82.6–90.4% [5–7], respectively. The results presented here
are consistent with the results of the above-mentioned studies,
which indicates that CEUS has clinical value in the identifica-
tion and diagnosis of benignity and malignancy of thyroid nod-
ules. In this study, 31 nodules weremisdiagnosed based only on
TI-RADS standards, and 32 nodules were misdiagnosed based
only on CEUS standards. A statistically significant difference
was not observed in the diagnostic accuracy of CEUS and TI-
RADS. Nineteen misdiagnosed nodules based only on TI-
RADS standards were correctly diagnosed by CEUS, and 20
misdiagnosed nodules based only on CEUS standards were
correctly diagnosed by TI-RADS. The results indicated that
the two methods may have complementary effects in the dif-
ferential diagnosis of thyroid nodules.
In our study, there were eight thyroid nodules coexisting
with Hashimoto s thyroiditis in our study, which were all ac-
curately diagnosed by CEUS and partly misdiagnosed by TI-
RADS. The result was consistent with that of Zhao et al. [13].
Table 11 Inter-observer









Experienced examiner 75 60 78 106 0.907 0.907
Inexperienced examiner 81 65 72 101
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The result indicated that CEUS is also effective in the diagno-
sis of malignant thyroid nodules coexisting with Hashimoto s
thyroiditis and can improve the diagnostic accuracy. Of five
inflammatory lesions, three nodules showed low-
enhancement mode and were misdiagnosed. It indicated that
CEUS may not be able to provide more valuable information
for inflammatory lesions, and further studies with greater sam-
ple size are required to validate the study results.
To increase the accuracy and reduce misdiagnoses as well
as missed diagnoses, we have combined CEUS with TI-
RADS to identify the benignity and malignancy of thyroid
nodules. Significant differences were observed when the com-
bined method was compared with CEUS alone or TI-RADS
alone, suggesting that a combined method can significantly
increase the accuracy of qualitative diagnoses of thyroid nod-
ules and effectively lower the misdiagnosis rate and missed
diagnosis rate. In the present study, we combined CEUS with
TI-RADS for further diagnosis analyses and found that nod-
ules with TI-RADS scores of 2, 4 and 5 did not present sig-
nificant differences (P > 0.05) when using the combined diag-
nosis, whereas nodules with TI-RADS scores of 4a and 4b
presented improved diagnoses by a combination of both
methods. Among the 56 4a-nodules, 55 were accurately diag-
nosed, and among the 52 4b-nodules, 44 were accurately di-
agnosed. These results indicate that a combination of both
methods primarily improved the identification and diagnosis
of scores 4a and 4b, which are difficult to identify by TI-
RADS alone, and it avoids the errors produced by TI-RADS
alone. Thus, we suggest that for thyroid nodules, particularly
for nodules with a TI-RADS score of 4a and 4b, a combina-
tion of both methods should be used for further analysis.
At logistic regression analysis of 4a and 4b thyroid nodules,
the following features showed an association with malignancy:
solid component, marked hypoechogenicity, irregular margins,
microcalcifications, taller than wide shape and low enhance-
ment. These results were consistent with those of Hyobin et al.
[14]. It further confirmed that the above features are effective
in the diagnosis of malignant thyroid nodules. To use TI-
RADS and CEUS on a regular basis in clinical routine it is
important that it is highly reliable. The inter-examiner mea-
surement agreement for TI-RADS and CEUS had a high pos-
itive correlation even between experienced and inexperienced
examiners (k = 0.885, k = 0.990, respectively). It indicated that
TI-RADS descriptors and CEUS mode are simple, objective
and are less influenced by US physicians’ experience.
Although a combination of both methods presents signifi-
cant improvements in diagnostic accuracy, 15 nodules were
still misdiagnosed, which may have been caused by the fol-
lowing: (1) certain benign nodules may have fibroplasias dur-
ing hyperplasia and form calcified fibrous septa and calcified
nodule walls, thereby affecting the interpretation of CEUS
images; (2) the contrast enhancement modes of certain benign
and malignant nodules in scores 4a and 4b could have
overlapped; (3) two malignant nodules that were diagnosed
as benign nodules were the nodular goitres with complications
from local papillary carcinoma and from local follicular can-
cer; this local carcinoma increased the difficulty of providing a
correct diagnosis; (4) the pathological results of the two
misdiagnosed TI-RADS score-5 nodules were inflammatory
lesions, and conventional US and CEUS results for such le-
sions are similar to malignant nodules, thereby increasing the
difficulty of providing a correct diagnosis.
The present study included the following limitations. (1)
Most of the malignant nodules were papillary carcinomas,
whereas most of the benign nodules were nodular goitres,
and fewer additional pathological types were analysed.
Therefore, the present study mainly confirms the diagnostic
value of TI-RADS and CEUS for papillary carcinoma and
nodular goitre, whereas the diagnostic value of these methods
for other benign and malignant thyroid pathological types re-
quires further investigation. (2) The present study represents a
single thyroid clinic’s work; thus, results have to be confirmed
with multi-centre studies and a large sample size.
In summary, CEUS and TI-RADS showed similar accura-
cy in the identification of benign and malignant thyroid nod-
ules. The improved TI-RADS combined with CEUS can sig-
nificantly increase the diagnostic accuracy for the qualitative
identification of thyroid nodules, particularly for TI-RADS
score 4a and 4b lesions, and if these findings can be replicated,
then it may be possible to reduce the number of patients sub-
jected to FNAB or short-term follow-up for benign-appearing
solid thyroid nodules.
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